Thyroid Lobectomy and Neck Dissection for N1b Papillary Thyroid Carcinoma
This cohort study found that a select group of patients with N1b PTC treated with TL had no important difference in survival and recurrence outcomes compared with patients treated with TT + RAI. Therefore, TL is an effective and safe treatment option in carefully selected and appropriately counselled patients with N1b PTC with unilateral tumors and low-volume regional lymph node metastases without clinical extranodal extension.
Authors
- Robert Michael Tuttle (ORCID: https://orcid.org/0000-0001-9899-9702)
- Snehal G. Patel (ORCID: https://orcid.org/0000-0003-1455-463X)
- Jennifer R. Cracchiolo (ORCID: https://orcid.org/0000-0003-4496-906X)
- Jatin P. Shah (ORCID: https://orcid.org/0000-0002-6444-6592)
- Ashok R. Shaha (ORCID: https://orcid.org/0000-0001-7478-9436)
- Daniel William Scholfield (ORCID: https://orcid.org/0000-0001-7784-1244)
- Lillian A. Boe (ORCID: https://orcid.org/0000-0001-6279-9987)
- Fergal Kavanagh (ORCID: https://orcid.org/0000-0001-8234-4744)
- Richard J. Wong (ORCID: https://orcid.org/0000-0001-6259-7314)
- Alana J. Eagan (ORCID: https://orcid.org/0009-0006-4987-7104)
- Helena Levyn (ORCID: https://orcid.org/0009-0005-4402-6186)
- Ian Ganly
Institutions
- Memorial Sloan Kettering Cancer Center (US)
Publication Details
- Journal
- JAMA Otolaryngology–Head & Neck Surgery
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1001/jamaoto.2025.4653
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00